Iron supplement with chemo and immunotherapy before gastric cancer surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether adding an iron supplement to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for patients with locally advanced gastric cancer. It aims to see if this approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gastric adenocarcinoma, a type of stomach cancer.
- Your cancer is locally advanced, meaning it has not spread to distant organs but may have reached nearby lymph nodes.
- You are between 18 and 75 years old.
- You are generally healthy enough to undergo treatment (able to perform daily activities).
- You have not had prior cancer treatment for this stomach cancer, including chemotherapy, immunotherapy, or iron supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a short course of radiation to a combination of chemotherapy and an immunotherapy drug (called a PD-1 inhibitor) before surgery helps shrink tumors and improve outcomes for people with upper stomach or gastroesophageal junction cancer.
This trial compares two types of IV iron treatments to see which one works better for people who have anemia after gastric cancer surgery. If you're eligible, you could get either ferric carboxymaltose or iron sucrose to help boost your iron levels and improve your anemia.
This study tests whether giving an iron infusion before surgery can improve outcomes for people with gastric cancer who are going to have their stomach removed. The goal is to see if it helps with recovery or reduces complications.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This Phase 3 study tests whether giving ferric carboxymaltose (an IV iron treatment) helps people with advanced stomach or stomach–esophagus cancer and iron-deficiency anemia. The goal is to improve safety and how well the standard first-line cancer treatment works.
This trial tests a combination of an immunotherapy drug (sintilimab) and a low-dose weekly chemotherapy regimen before surgery for locally advanced stomach cancer that can be removed. The goal is to see if this approach helps shrink the tumor and improve outcomes.
Hear when a new Gastric Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.